# GLIADEL
> **NDA020637** · New Drug Application · Sponsor: AZURITY · Approved 1996-09-23
## Drug
- **FDA Application Number:** NDA020637
- **Application type:** New Drug Application
- **Brand name:** GLIADEL
- **Generic name:** CARMUSTINE
- **Active ingredients:** CARMUSTINE
- **Dosage form:** IMPLANT
- **Route:** INTRACRANIAL
- **Marketing status:** Prescription
- **Sponsor:** AZURITY
- **Manufacturer:** Azurity Pharmaceuticals, Inc.
- **First approval:** 1996-09-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020637)
---
*MORVS · CC0 1.0*